RxDoctor Payments DataLook up a doctor →

Tonya Fraser, PA

Medical · Charlotte, NCNPI 1508839226

Payments from drug & device makers

$15,541in general payments, 2019–2025

Across 823 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • Pfizer$2K
  • Bayer$922
  • AstraZeneca$908
  • Boehringer Ingelheim$734
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)130$2,372
Novo Nordisk106$1,859
Pfizer84$1,636
Bayer57$922
AstraZeneca40$908
Boehringer Ingelheim35$734
Exact Sciences14$630
Lilly USA, LLC30$578
Astellas Pharma US Inc25$540
Amgen(2 entities)28$421
Takeda Pharmaceuticals U.S.A., Inc.22$370
GSK17$324
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$312
Johnson & Johnson15$270
Biohaven Pharmaceutical Holding Company Ltd.16$237
Novartis15$229
Axsome Therapeutics, Inc.11$222
Biohaven Pharmaceuticals, Inc.12$200
Abbott11$186
Esperion Therapeutics, Inc.10$170
Sumitomo Pharma America, Inc.8$156
Xeris Pharmaceuticals, Inc.9$154
Merck8$142
Bausch Health US, LLC8$132
Treace Medical Concepts, Inc.1$121
Paratek Pharmaceuticals, Inc.7$105
Kowa Pharmaceuticals America, Inc.6$102
Eisai Inc.5$92
Idorsia Pharmaceuticals US Inc5$86
Insightec,inc2$85
Amneal Pharmaceuticals LLC4$79
Corcept Therapeutics4$75
Neos Therapeutics, LP4$73
Teva Pharmaceuticals USA, Inc.3$70
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$61
Jazz Pharmaceuticals Inc.4$61
Amarin Pharma, Inc.3$61
Daiichi Sankyo Inc.3$60
Arbor Pharmaceuticals, Inc.3$55
Medtronic3$53
Sanofi-aventis U.S. LLC3$52
Shield Therapeutics Inc3$49
Phathom Pharmaceuticals, Inc.3$48
E.r. Squibb & Sons, L.L.C.3$42
Medicure Pharma Inc.1$40
Dexcom, Inc.2$37
Sunovion Pharmaceuticals Inc.2$35
Inspire Medical Systems, Inc.2$35
Mayne Pharma Commercial LLC3$34
Boston Scientific1$28
Ironwood Pharmaceuticals, Inc1$24
Antares Pharma, Inc.1$21
Convatec Inc.1$21
Vyera Pharmaceuticals, LLC1$20
Edwards Lifesciences1$18
Supernus Pharmaceuticals, Inc.1$18
GRT US Holding, Inc.1$17
Currax Pharmaceuticals LLC1$16
Organon1$16
Upsher-smith Laboratories LLC1$15

How this compares

$15,541 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina →

Medicare billing

Part B allowed, 2024
$43,389
Medicare patients
194
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Charlotte

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →